company background image
6677

Anxo Pharmaceutical TPEX:6677 Stock Report

Last Price

NT$20.70

Market Cap

NT$1.0b

7D

-3.9%

1Y

-5.5%

Updated

04 Oct, 2022

Data

Company Financials
6677 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

6677 Stock Overview

Anxo Pharmaceutical Co., Ltd., a specialty pharmaceutical company, develops, manufactures, and sells pharmaceutical products for medical professionals and patients in Taiwan and internationally.

Anxo Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Anxo Pharmaceutical
Historical stock prices
Current Share PriceNT$20.70
52 Week HighNT$26.25
52 Week LowNT$16.30
Beta-0.032
1 Month Change-3.72%
3 Month Change6.15%
1 Year Change-5.50%
3 Year Change-34.14%
5 Year Changen/a
Change since IPO-56.94%

Recent News & Updates

Dec 30
These 4 Measures Indicate That Anxo Pharmaceutical (GTSM:6677) Is Using Debt Extensively

These 4 Measures Indicate That Anxo Pharmaceutical (GTSM:6677) Is Using Debt Extensively

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Shareholder Returns

6677TW PharmaceuticalsTW Market
7D-3.9%-2.2%-3.5%
1Y-5.5%19.5%-18.3%

Return vs Industry: 6677 underperformed the TW Pharmaceuticals industry which returned 19.5% over the past year.

Return vs Market: 6677 exceeded the TW Market which returned -18.3% over the past year.

Price Volatility

Is 6677's price volatile compared to industry and market?
6677 volatility
6677 Average Weekly Movement5.6%
Pharmaceuticals Industry Average Movement5.4%
Market Average Movement5.1%
10% most volatile stocks in TW Market8.2%
10% least volatile stocks in TW Market2.4%

Stable Share Price: 6677 is not significantly more volatile than the rest of TW stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: 6677's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2003n/an/ahttps://www.anxo.com.tw

Anxo Pharmaceutical Co., Ltd., a specialty pharmaceutical company, develops, manufactures, and sells pharmaceutical products for medical professionals and patients in Taiwan and internationally. It offers prescription and over the counter drugs in various therapeutic areas, such as cardiovascular, metabolism, CNS, diabetic, gastroenterology, respiratory, anti-infection, dermatology, nephrology, urology, orthopedics, etc. The company was founded in 2003 and is headquartered in Taipei, Taiwan.

Anxo Pharmaceutical Co., Ltd. Fundamentals Summary

How do Anxo Pharmaceutical's earnings and revenue compare to its market cap?
6677 fundamental statistics
Market CapNT$1.04b
Earnings (TTM)-NT$20.99m
Revenue (TTM)NT$793.32m

1.3x

P/S Ratio

-47.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
6677 income statement (TTM)
RevenueNT$793.32m
Cost of RevenueNT$500.05m
Gross ProfitNT$293.27m
Other ExpensesNT$314.26m
Earnings-NT$20.99m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.44
Gross Margin36.97%
Net Profit Margin-2.65%
Debt/Equity Ratio107.3%

How did 6677 perform over the long term?

See historical performance and comparison